Investing Ideas
/
Chinese Pharmaceuticals & Biotech Your first investment

Chinese Pharmaceuticals & Biotech Your first investment

Results

0 new

Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

9 companies

Yunnan Baiyao GroupLtd

Market Cap: CN¥88.9b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

000538

CN¥49.80

-2.7%

-12.4%

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥78.5b

Manufactures and distributes pharmaceuticals and cosmetics in China and internationally.

600436

CN¥130.18

-6.9%

-35.3%

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥40.6b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

CN¥24.40

-3.4%

-19.5%

Beijing Tongrentang

Market Cap: CN¥33.5b

Engages in the production and sale of traditional Chinese medicine preparations in China and internationally.

600085

CN¥24.44

-2.8%

-32.9%

Dong-E-E-Jiao

Market Cap: CN¥32.9b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

000423

CN¥51.50

-4.7%

2.2%

Apeloa PharmaceuticalLtd

Market Cap: CN¥25.0b

Provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally.

000739

CN¥22.20

-4.5%

34.5%

Livzon Pharmaceutical Group

Market Cap: CN¥24.2b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

000513

CN¥30.05

-2.2%

-26.4%

Tasly Pharmaceutical Group

Market Cap: CN¥22.9b

Engages in the research, development, production, and sale of pharmaceuticals in China.

600535

CN¥15.36

-1.7%

-9.9%

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥16.5b

Engages in the research, development, production, and sale of biological products, traditional Chinese medicines, chemical medicines, and other drugs in China and internationally.

600867

CN¥8.46

1.0%